Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | THEO-260 |
Trade Name | |
Synonyms | THEO 260|THEO260 |
Drug Descriptions |
THEO-260 is an oncolytic adenovirus that may induce lysis of tumor cells and cancer-associated fibroblasts, potentially resulting in decreased tumor growth (J Clin Oncol, 41, no. 16_suppl (2023) e14573, Ann Oncol (2023) 34 (suppl_2): S1166). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
THEO-260 | THEO-260 | 0 | 1 |